Company: LRHC
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112656
Chunk: 185

Company: La Rosa Holdings Corp.
Filing Date: 2025-11-19
Form: 10-Q
Item: Item 8
Chunk 185
---
 passu with any parity stock then outstanding, an amount per share of Series B Preferred
stock equal to the greater of (A) 125% of the conversion amount and (B) the amount per share that such Series B Preferred Stock holder
would receive if converted into common stock immediately prior to the date of such payment.

Share
Repurchase Program

On
April 23, 2025, the Company’s Board of Directors approved a new Share Repurchase Program, which authorizes the Company to purchase
up to an aggregate of $500,000 of the Company’s outstanding shares of common stock in the open market in accordance with all applicable
securities laws and regulations. Repurchases under this program may be made at management’s discretion at the time and in the amounts
determined by the Chief Executive Officer and Chief Operating Officer of the Company. The Share Repurchase Program has an expiration
date of December 31, 2025.

Common
Stock Issuances  

On
January 17, 2025, the Company issued 4,995 shares of common stock as an exercise of a prefunded warrant which was part of the securities
purchase agreement with an institutional accredited investor, Abri Advisors, Ltd., a corporation organized under the laws of Bermuda,
agreed to on November 1, 2024.

On February 5, 2025, the Company issued the CEO
an aggregate of 36,665 unregistered shares of common stock of the Company, par value $0.0001 per share (the “Shares”) as a
compensation for the services rendered pursuant to his employment agreement with the Company. The Company issued the Shares to the CEO
in reliance on exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”),
available to the Company under Section 4(a)(2) of the Securities Act due to the fact that the issuance did not involve a public offering
of securities. The stock compensation expense for the three and nine months ended September 30, 2025, was $0 and $1,160,381, respectively.

30

La
Rosa Holdings Corp. and Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial Statements

On February 20, 2025, the Company issued shares
pursuant a consulting agreement entered into on January 1, 2025 in which the Company agreed to issue 21,545 shares of the Company’s
common